Hybrid AF TM Therapy

An FDA Approved Device for Atrial Fibrillation

An estimated 8 million people have atrial fibrillation (Afib, AF) in the U.S.1 The FDA approved Hybrid AFTM Therapy as a safe and effective option to treat the over 3.5 million people with long-standing persistent Afib. Nearly 2x more effective than existing therapy options, Hybrid AF Therapy offers new hope for patients with long-standing persistent atrial fibrillation.2

 

Hybrid AF Therapy Benefits
 

 

Take a Quiz to Find Out If You Have Atrial Fibrillation

 

Sources

  1. Colilla, S. et al. (2013). Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol, 112(8):1142-1147.
  2. IFU for EPi-Sense® Guided Coagulation System Data: PMA# P200002
PM-US-1638B-0725-G
© 2023 Atricure, Inc. All Rights Reserved.